![Hiroko Kimura](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hiroko Kimura
Directeur/Membre du Conseil chez
Sonire Therapeutics, Inc. (TY)
Profil
Hiroko Kimura currently works at Rin Institute, Inc., as Director, Sonire Therapeutics, Inc. (TY), as Outside Director, and Fast Track Initiative, Inc., as Principal.
Postes actifs de Hiroko Kimura
| Sociétés | Poste | Début |
|---|---|---|
Fast Track Initiative, Inc.
 Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Analyste en capital-investissement | 01/08/2013 |
Rin Institute, Inc.
 Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody medicine for the diagnosis and treatment of cancer | Directeur/Membre du Conseil | - |
Sonire Therapeutics, Inc. (TY)
 Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Research and develops ultrasound treatment equipment | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
29
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Fast Track Initiative, Inc.
Fast Track Initiative, Inc. Investment ManagersFinance Fast Track Initiative invests in companies located in Japan and the United States. The firm targets companies operating in the fields of the life science community including therapeutics, diagnostics, digital health, healthcare services, and more sectors. It provides financing for seed and early stages capital requirements. It also makes follow-on investments. | Finance |
Rin Institute, Inc.
Rin Institute, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody medicine for the diagnosis and treatment of cancer | Health Technology |
Sonire Therapeutics, Inc. (TY)
Sonire Therapeutics, Inc. (TY) Medical SpecialtiesHealth Technology Research and develops ultrasound treatment equipment | Health Technology |
